Agardh E, Hultberg B, Agardh C
Department of Ophthalmology, University Hospital MAS, Malmö, Sweden.
Curr Eye Res. 2000 Jul;21(1):543-9.
To study effects of inhibition of glycation, and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Diabetes was induced in male Wistar rats with streptozocin (STZ; 60 mg/kg BW, i.p.). Diabetic as well as strain matched control rats were fed 1) a normal diet, 2) addition of aminoguanidine in the drinking water (0.5 g/l for diabetic rats and 1.0 g/l for control rats) or 3) probucol in the pellets (1% w/w). After 6 months, the number of acellular vessels, endothelial cells and pericytes were counted in trypsin digested retinal vessel preparations, and the total retinal tissue amount of glutathione (GSH) and cysteine was measured with HPLC.
Cataract formation occurred after 13 weeks in diabetic animals compared with 17 weeks for those treated with aminoguanidine, and 16 weeks for those treated with probucol (p < 0.001 in both cases). Aminoguanidine inhibited the formation of acellular collapsed capillary strands, 9 (3-14) vs. 18 (12-262) (median, range) per quadrant in untreated diabetic rats (p = 0.004), while probucol did not have any effect. Neither aminoguanidine, nor probucol influenced the endothelial/pericyte ratio. Diabetes caused a reduction in the GSH/cysteine ratio (10.7 +/- 0.6 vs. 15.3 +/- 1. 5) (mean +/- SD; p < 0.001). Probucol partly restored this imbalance (p < 0.05) whereas aminoguanidine did not.
The results indicate that cataract formation in diabetes involves both glycation and oxidative stress processes. The reduced formation of acellular collapsed capillary strands by aminoguanidine suggests a potential role for glycation in vascular damage. The positive effect of probucol on cysteine/GSH metabolism imbalance indicates that derangements of one of the retinal defense systems against oxidative stress can be normalized by antioxidants.
研究抑制糖基化和氧化应激对糖尿病大鼠白内障形成及视网膜血管异常发展的影响。
用链脲佐菌素(STZ;60mg/kg体重,腹腔注射)诱导雄性Wistar大鼠患糖尿病。糖尿病大鼠以及品系匹配的对照大鼠分别喂食:1)正常饮食;2)饮水中添加氨基胍(糖尿病大鼠为0.5g/L,对照大鼠为1.0g/L);3)颗粒饲料中添加普罗布考(1%w/w)。6个月后,在胰蛋白酶消化的视网膜血管制剂中计数无细胞血管、内皮细胞和周细胞的数量,并用高效液相色谱法测定视网膜组织中谷胱甘肽(GSH)和半胱氨酸的总量。
糖尿病动物在13周后出现白内障形成,而用氨基胍治疗的动物为17周,用普罗布考治疗的动物为16周(两种情况均p<0.001)。氨基胍抑制了无细胞塌陷毛细血管束的形成,未治疗的糖尿病大鼠每象限9(3 - 14)个,而未治疗的糖尿病大鼠为18(12 - 262)个(中位数,范围)(p = 0.004),而普罗布考没有任何作用。氨基胍和普罗布考均未影响内皮细胞/周细胞比例。糖尿病导致GSH/半胱氨酸比值降低(10.7±0.6对15.3±1.5)(平均值±标准差;p<0.001)。普罗布考部分恢复了这种失衡(p<0.05),而氨基胍没有。
结果表明糖尿病中的白内障形成涉及糖基化和氧化应激过程。氨基胍减少无细胞塌陷毛细血管束的形成表明糖基化在血管损伤中可能起作用。普罗布考对半胱氨酸/GSH代谢失衡的积极作用表明,抗氧化剂可使视网膜抗氧化应激防御系统之一的紊乱恢复正常。